Header Logo

Connection

Shannon Conley to Nanoparticles

This is a "connection" page, showing publications Shannon Conley has written about Nanoparticles.
Connection Strength

1.324
  1. Nanoparticles for retinal gene therapy. Prog Retin Eye Res. 2010 Sep; 29(5):376-97.
    View in: PubMed
    Score: 0.264
  2. DNA nanoparticles are safe and nontoxic in non-human primate eyes. Int J Nanomedicine. 2018; 13:1361-1379.
    View in: PubMed
    Score: 0.113
  3. Genomic DNA nanoparticles rescue rhodopsin-associated retinitis pigmentosa phenotype. FASEB J. 2015 Jun; 29(6):2535-44.
    View in: PubMed
    Score: 0.092
  4. Rim formation is not a prerequisite for distribution of cone photoreceptor outer segment proteins. FASEB J. 2014 Aug; 28(8):3468-79.
    View in: PubMed
    Score: 0.087
  5. Episomal maintenance of S/MAR-containing non-viral vectors for RPE-based diseases. Adv Exp Med Biol. 2014; 801:703-9.
    View in: PubMed
    Score: 0.085
  6. Gene therapy for Stargardt disease associated with ABCA4 gene. Adv Exp Med Biol. 2014; 801:719-24.
    View in: PubMed
    Score: 0.085
  7. Synthesis and characterization of glycol chitosan DNA nanoparticles for retinal gene delivery. ChemMedChem. 2014 Jan; 9(1):189-96.
    View in: PubMed
    Score: 0.084
  8. Comparative analysis of DNA nanoparticles and AAVs for ocular gene delivery. PLoS One. 2012; 7(12):e52189.
    View in: PubMed
    Score: 0.079
  9. DNA nanoparticle-mediated ABCA4 delivery rescues Stargardt dystrophy in mice. J Clin Invest. 2012 Sep; 122(9):3221-6.
    View in: PubMed
    Score: 0.077
  10. AAV and compacted DNA nanoparticles for the treatment of retinal disorders: challenges and future prospects. Invest Ophthalmol Vis Sci. 2011 May 10; 52(6):3051-9.
    View in: PubMed
    Score: 0.071
  11. Gene delivery to mitotic and postmitotic photoreceptors via compacted DNA nanoparticles results in improved phenotype in a mouse model of retinitis pigmentosa. FASEB J. 2010 Apr; 24(4):1178-91.
    View in: PubMed
    Score: 0.064
  12. Ocular delivery of compacted DNA-nanoparticles does not elicit toxicity in the mouse retina. PLoS One. 2009 Oct 12; 4(10):e7410.
    View in: PubMed
    Score: 0.063
  13. A partial structural and functional rescue of a retinitis pigmentosa model with compacted DNA nanoparticles. PLoS One. 2009; 4(4):e5290.
    View in: PubMed
    Score: 0.061
  14. Nanoparticle applications in ocular gene therapy. Vision Res. 2008 Feb; 48(3):319-24.
    View in: PubMed
    Score: 0.055
  15. Non-viral therapeutic approaches to ocular diseases: An overview and future directions. J Control Release. 2015 Dec 10; 219:471-487.
    View in: PubMed
    Score: 0.024
  16. S/MAR-containing DNA nanoparticles promote persistent RPE gene expression and improvement in RPE65-associated LCA. Hum Mol Genet. 2013 Apr 15; 22(8):1632-42.
    View in: PubMed
    Score: 0.020
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.